Literature DB >> 15947025

Gene expression profiling of 17beta-estradiol and genistein effects on mouse thymus.

Vimal Selvaraj1, David Bunick, Carrol Finnigan-Bunick, Rodney W Johnson, Huixia Wang, Lei Liu, Paul S Cooke.   

Abstract

Estrogen regulates thymic development and involution and modulates immune function. Despite its critical role in thymus, as well as in autoimmune disorders, the mechanism by which estrogen affects the thymus is not well understood. We previously reported that the estrogenic soy isoflavone genistein, as well as 17beta-estradiol (E2), could induce thymic involution, but genistein effects were only partially mediated through estrogen receptors. To provide insights into mechanisms of estrogenic effects in the thymus, we investigated thymic gene expression changes induced by E2 (125 ng/day) and genistein (1500 ppm in feed) in weanling mice using high-density DNA arrays. We identified several E2-responsive genes involved in thymic development and thymocyte signaling during selection and maturation. Functional characterization indicated effects on genes involved in transcription, apoptosis, and the cell cycle. This study also identified changes in several E2-regulated transcripts essential to maintain immune self-tolerance. E2 upregulated more genes than genistein, while genistein downregulated more genes than E2. Though each treatment regulated several genes not altered by the other, there was considerable overlap in the genes regulated by E2 and genistein. Changes in transcription factors and cell cycle factors were consistent with decreases in cell proliferation induced by both genistein and E2. As indicated by the regulation of non-E2-responsive genes, genistein also induced unique effects through non-estrogenic mechanisms. The specific downregulation of the CD4 coreceptor transcript by genistein was consistent with the decline of CD4+ thymocytes in genistein-treated mice in our previous study. This is the first study identifying E2 and genistein target genes in the thymus. These findings provide new mechanistic insights toward explaining estrogen action on thymocyte development, selection, and maturation, as well as the effects of genistein on prenatal and neonatal thymic development and function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15947025     DOI: 10.1093/toxsci/kfi219

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  6 in total

Review 1.  Role of gonadal hormones in programming developmental changes in thymopoietic efficiency and sexual diergism in thymopoiesis.

Authors:  Gordana Leposavic; Milica Perisic; Ivan Pilipovic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

2.  Predicting environmental chemical factors associated with disease-related gene expression data.

Authors:  Chirag J Patel; Atul J Butte
Journal:  BMC Med Genomics       Date:  2010-05-06       Impact factor: 3.063

3.  Genistein modulation of streptozotocin diabetes in male B6C3F1 mice can be induced by diet.

Authors:  Tai L Guo; Yunbiao Wang; Tao Xiong; Xiao Ling; Jianfeng Zheng
Journal:  Toxicol Appl Pharmacol       Date:  2014-08-30       Impact factor: 4.219

4.  Effect of Genistein and L-carnitine and Their Combination on Lipid Profile and Inflammatory Cytokines in Experimental Nephrotic Syndrome.

Authors:  Abbas Yousefinejad; Fereydoon Siassi; Mohammad Hassan Javanbakht; Hamed Mohammadi; Ehsan Ghaedi; Mahnaz Zarei; Ehsan Djalali; Mahmoud Djalali
Journal:  Rep Biochem Mol Biol       Date:  2018-10

Review 5.  Isoflavones, their Glycosides and Glycoconjugates. Synthesis and Biological Activity.

Authors:  Wiesław Szeja; Grzegorz Grynkiewicz; Aleksandra Rusin
Journal:  Curr Org Chem       Date:  2017-01       Impact factor: 2.180

6.  Next-generation text-mining mediated generation of chemical response-specific gene sets for interpretation of gene expression data.

Authors:  Kristina M Hettne; André Boorsma; Dorien A M van Dartel; Jelle J Goeman; Esther de Jong; Aldert H Piersma; Rob H Stierum; Jos C Kleinjans; Jan A Kors
Journal:  BMC Med Genomics       Date:  2013-01-29       Impact factor: 3.063

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.